CLPT.NASDAQClearpoint Neuro, INC
Form 4: ClearPoint Neuro Director Timothy T. Richards Reports Stock Transactions
Sentiment:
SEC Form 4 Filing
Director Timothy T. Richards reports the conversion of restricted stock units into common stock.
Summary
- On May 14, 2024, Timothy T. Richards, a director of ClearPoint Neuro, Inc., reported a transaction involving the conversion of 17,153 restricted stock units into common stock.
- Following the transaction, Richards beneficially owns 61,561 shares of common stock.
- The restricted stock units were granted on May 25, 2023, and vested on the earlier of the first anniversary of the grant date or the day immediately preceding the company's 2024 annual meeting of stockholders.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/25/2023 | Reporting person was granted 17,153 restricted stock units. |
| 05/14/2024 | Restricted stock units converted into common stock. |
| 05/15/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.